[Submicroscopic aspects of the mechanism of inhibitors of H+/K+-ATPase in gastric parietal cells].
In most developed countries of the world the basis of the ulcer treatment is formed by H+/K(+)-ATPase blockers: omeprazole, pantoprazole, lansoprazole etc. though in accordance with the Maastricht treaty (2) the first line therapy may also be based upon the application of one of H2-histamine receptor blockers, specifically the two-component ranitidine bismuth citrate preparation.